Prostate Cancer News

UCLA's effort to patent a costly prostate cancer drug in India hurts ... - Los Angeles Times



Los Angeles Times
 
UCLA's effort to patent a costly prostate cancer drug in India hurts ... 
Los Angeles Times
Two consumer groups are urging UCLA to drop its patent on Xtandi, a costly prostate cancer drug developed at the university.

and more » 


Research Notebook: Possible new prostate cancer therapy - Shreveport Times



Shreveport Times
 
Research Notebook: Possible new prostate cancer therapy 
Shreveport Times
Research Notebook is a recurring series highlighting research activities at LSU Health Shreveport. Today's notebook looks at a recent grant focusing on prostate cancer. A researcher at LSU Health Shreveport was recently awarded a Department of Defense ...

 


How nerves fuel prostate cancer growth - Medical News Today - Medical News Today



Medical News Today
 
How nerves fuel prostate cancer growth - Medical News Today 
Medical News Today
Researchers from the Albert Einstein College of Medicine have pinpointed how certain nerves drive the growth of prostate cancer using a metabolic 'switch.'
Researchers reveal how certain nerves sustain prostate cancer growth News-Medical.net

all 2 news articles » 


SIU 2017: Oligometastatic Bone Disease in Prostate Cancer Patients Treated on the TROG 03.04 RADAR Trial - UroToday



SIU 2017: Oligometastatic Bone Disease in Prostate Cancer Patients Treated on the TROG 03.04 RADAR Trial 
UroToday
In this second Major Observation, Dr. Egawa discussed a paper by Sridharan et al, which focused on prostate cancer oligometastatic disease treated with radiotherapy as part of the TROG 03.04 RADAR study. In this study, patients with pT2aN0M0 ...

 


SIU 2017: Artificial Intelligence (AI) Can More Efficiently Predict ... - UroToday



SDE Entertainment News
 
SIU 2017: Artificial Intelligence (AI) Can More Efficiently Predict ... 
UroToday
SIU2017, prostate cancer, concept of artificial intelligence, computer learning to help manage patients with elevated PSA, Neural network back progression, ...
My battle with prostate cancer: How a 75-year-old survived the ... SDE Entertainment News

all 18 news articles » 


Prostate cancer survivor turned health advocate for millions of men - MyCentralJersey.com



MyCentralJersey.com
 
Prostate cancer survivor turned health advocate for millions of men 
MyCentralJersey.com
Rutgers University-Newark alumnus Virgil Simons has created an international nonprofit network to provide education and support.

and more » 


Hormone therapy for prostate cancer increases cardiac risk - Medical News Today



Medical News Today
 
Hormone therapy for prostate cancer increases cardiac risk 
Medical News Today
Androgen-deprivation therapy is widely used to treat prostate cancer. In a recent study, the potential risks to heart health are examined.

and more » 


Holy Family Hospital Announces Advanced Diagnostic Testing Options for Prostate Cancer - WHAV News



WHAV News
 
Holy Family Hospital Announces Advanced Diagnostic Testing Options for Prostate Cancer 
WHAV News
Holy Family Hospital has announced new prostate cancer testing options will be implemented at their Methuen and Haverhill campuses. To more accurately diagnose the disease, Holy Family will take advantage of targeted mpMRI Fusion biopsies, which ...

 


Prostate cancer: 5 things to know - Florida Today - Florida Today



Florida Today
 
Prostate cancer: 5 things to know - Florida Today 
Florida Today
Prostate cancer is the most common cancer among men after skin cancer but it can often be treated successfully.
Age Matters: What is role of PSA in prostate cancer? Roanoke Times
'Donald Trump's hair-growth drug may cut prostate cancer risk' Times Now

all 4 news articles » 


The importance of the mitochondrial genome - Nature.com



The importance of the mitochondrial genome 
Nature.com
An analysis of the mitochondrial genome of patients with prostate cancer shows that mutations in mitochondrial DNA are frequent and associate with nuclear DNA mutations. In addition, mitochondrial mutations were shown to correlate with risk of ...